Neuroblastoma Maintenance Therapy Trial

NCT02679144 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

441

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma

Interventions

DRUG: Difluoromethylornithine (DFMO)

Sponsor

Giselle Sholler

Collaborators

[object Object]
[object Object]